- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT02688192
Mobile Health Fitness Program for Adolescent and Young Adult Childhood Cancer Survivors (TLCFIT)
Teens Living With Cancer Fitness Improvement Training (TLCFIT): A Novel Mobile Health Fitness Program for Adolescent and Young Adult (AYA) Childhood Cancer Survivors
Přehled studie
Postavení
Detailní popis
PRIMARY OBJECTIVES:
I. Evaluate the feasibility of the technology-enhanced (electronic accelerometer + app + 8 weekly group sessions) fitness program in a pilot randomized clinical trial.
SECONDARY OBJECTIVES:
I. Determine the effectiveness of the technology-enhanced fitness program on participants' cardiorespiratory fitness and muscular fitness.
II. Examine the effects of the program on secondary outcomes of health related quality of life (HRQOL) and fatigue.
OUTLINE:
Participants are randomized to 1 of 2 arms.
ARM I (Intervention): Participants attend 8 group meetings weekly, wear an electronic accelerometer, engage in private social support messaging within the app and Facebook private groups, and then use the mobile app for 4 weeks without in-person groups.
ARM II (WAITLIST CONTROL [WLC]): After the 6 month assessment, participants receive the FitSurvivor intervention as in arm I.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
New Jersey
-
Hackensack, New Jersey, Spojené státy, 07601
- Hackensack University Medical Center
-
New Brunswick, New Jersey, Spojené státy, 08903
- Rutgers Cancer Institute of New Jersey
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Any diagnosis of cancer prior to age 21
- Off treatment for at least 6 months
- For patients < 18 years, parents must give informed consent and patient must give assent; patients >= 18 must give informed consent
Exclusion Criteria:
- Any medical contraindication to exercise according to a physician or physician's designee
- Non-English speaking
- Current physical activity level exceeding Centers for Disease Control and Prevention (CDC) guidelines for activity (60 min of moderate-vigorous exercise/day for 5+ days/week (wk) including 3+ days of vigorous intensity activities and muscle-strengthening exercises on 3+ days/wk and bone strengthening exercises on 3+ days/wk for children < 18 and 150 min of moderate vigorous exercise or 75 min of vigorous exercise/wk and 2+ days of muscle strengthening activities for adults >= 18); the CDC guidelines are used to determine exercise prescription in our intervention; individuals already exceeding the guidelines would be unlikely to benefit from participating
- Significant developmental delay per patient, parent, or physician report
- Pregnant (per patient report); if participant becomes pregnant during the course of the study, she will be removed from further participation
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Podpůrná péče
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Arm I (Intervention)
Assessment including
|
Pomocná studia
Ostatní jména:
Participate in fitness program
Engage in private social support messaging and Use the mobile app
Wear an electronic accelerometer
Ostatní jména:
|
|
Aktivní komparátor: Arm II (Waitlist Control [WLC])
Assessment including
After waiting 6 months they will begin the fitness program as described in Arm I |
Pomocná studia
Ostatní jména:
Participate in fitness program
Engage in private social support messaging and Use the mobile app
Wear an electronic accelerometer
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Feasibility of the Technology-enhanced Fitness Program
Časové okno: Baseline
|
Feasibility will be evaluated by the number of participants who enroll and complete baseline assessment for the randomized trial.
In total, 354 participants were mailed letters; 68 were contacted/screened, of which 56 were eligible and 49 enrolled (88% of those screened eligible, 14% of total potentially eligible pool).
|
Baseline
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Feasibility - Retention
Časové okno: Baseline to post-intervention (3 months)
|
Percentage of participants who compete the 3 month assessment
|
Baseline to post-intervention (3 months)
|
|
Fatigue Measured Using the PedsQL Multidimensional Fatigue Scale
Časové okno: Baseline to post-intervention (3 months)
|
Fatigue measured using the PedsQL Multidimensional Fatigue Scale.
The PedsQL Multidimensional Fatigue Scale yields three subscales: general, sleep/rest, and cognitive fatigue.
Scores are transformed on a 0-100 scale, with higher scores indicating better functioning.
|
Baseline to post-intervention (3 months)
|
|
Health Related Quality of Life (HRQL) Measured Using the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scale
Časové okno: Baseline to post-intervention (3 months)
|
The PedsQL Generic Core Scale is a well-validated measure of HRQOL with physical, emotional, social, and cognitive functioning domains.
The PedsQL Generic Core yields two summary scores - Physical Summary and Psychosocial Summary.
Scores are transformed on a 0-100 scale, with higher scores indicating better functioning.
|
Baseline to post-intervention (3 months)
|
|
Change in Cardiorespiratory Fitness Measured Using Submaximal Treadmill Test
Časové okno: Baseline to post-intervention (3 months)
|
Cardiorespiratory fitness was measured via submaximal treadmill testing using a modified Bruce protocol.
This standardized graded treadmill test adds two warm-up stages, with the first performed at a 1.7 mph and 0% grade and the second at 1.7 mph and 5% grade.
Participants performed the graded exercise test until they reached 85% of their age-predicted maximum heart rate, which was measured using a chest-worn Polar heart rate monitor.
Estimated VO2 max was calculated for each participant using the multi-stage model and American College of Sports Medicine metabolic equations.
|
Baseline to post-intervention (3 months)
|
|
Change in Muscle Strength/Endurance Measured Using 10-repetition Maximum Strength Tests (Upper and Lower Body)
Časové okno: Baseline to post-intervention (3 months)
|
Lower and upper body muscular strength/endurance were measured via 10-repetition maximum (10-RM) tests following National Strength and Conditioning Association guidelines (leg press machine for lower body and barbell bench press for upper body).
Weight was increased until participants executed 10 repetitions in good form for both exercises.
Estimates of 1-RM leg and bench press were made using a linear prediction equation.
Higher scores indicate greater muscular strength/endurance.
|
Baseline to post-intervention (3 months)
|
|
Feasibility - Engagement With the App
Časové okno: Duration of the FitSurvivor intervention (12 weeks)
|
Engagement with the app was measured by 1) number of in-app exercises completed; 2) points earned (more active = more points); 3) achievements unlocked; and 4) number of likes and comments posted within the social feed.
These are count data.
Achievements unlocked has possible range of 0 to 20.
Number of in-app exercises completed, points earned, and number of likes and comments posted within the social feed have a possible lower limit of 0 and no upper limit; higher numbers indicate more instances of each.
The full range of participant data are: number of in-app exercises completed = 0-44; points earned = 0-1,195; number of achievements unlocked = 1-20; number of likes/comments posted = 0-8.
|
Duration of the FitSurvivor intervention (12 weeks)
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: Katie Devine, Rutgers Cancer Institute of New Jersey
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- Pro2013003658
- P30CA072720 (Grant/smlouva NIH USA)
- NCI-2015-01841 (Identifikátor registru: CTRP (Clinical Trial Reporting Program))
- 131323 (Jiný identifikátor: Rutgers Cancer Institute of New Jersey)
- K07CA174728 (Grant/smlouva NIH USA)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Hodnocení kvality života
-
Memorial Sloan Kettering Cancer CenterUkončenoRodiny nebo nejbližší příbuzní pacientů léčených v MSKCC pro nekutánní spinocelulární karcinomy | Horní aerodigestivní traktSpojené státy
-
University of MiamiNábor
-
Johns Hopkins UniversityNational Institute on Aging (NIA)DokončenoDelirium | Zlomeniny kyčleSpojené státy
-
Azienda Ospedaliera Universitaria Integrata VeronaNeznámý
-
Dana-Farber Cancer InstituteEMD Serono; National Comprehensive Cancer NetworkNáborRakovina močového měchýře | Uroteliální karcinom | Metastatická rakovina močového měchýře | Neresekabilní karcinom močového měchýřeSpojené státy
-
Bursa Yüksek İhtisas Education and Research HospitalDokončenoPooperační nevolnost a zvracení | ŽvýkačkaKrocan
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceNábor
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenZatím nenabírámeChemoterapií indukovaná periferní neuropatie | CIPN - Chemoterapií indukovaná periferní neuropatie | Periferní neuropatie vyvolaná chemoterapií u rakoviny prsuBelgie
-
University Hospital, ToulouseNáborCévní mozková příhodaFrancie
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)NáborNemalobuněčný karcinom plic | Stav výkonuSpojené státy